Acadia Investors Get Class Cert. In Suit Over Parkinson’s Drug

By Bonnie Eslinger (March 11, 2024, 10:55 PM EDT) — A California federal judge on Monday certified a class of Acadia Pharmaceuticals investors in a lawsuit accusing the company of making false and misleading statements regarding the likelihood that its Parkinson’s psychosis drug would also be approved for the broader use of dementia-related psychosis….

Adblock test (Why?)

This was shown first on:

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *